Finance

Lists
Why is AVXL down 6,66%?
Dive Deeper
AVXL:NASDAQ
Anavex Life Sciences Corp
0,99 $
-6,66%
(-0,071) 1D
1,01 $
+2,08% (+0,021)
Pre-market
Closed: 12 қар., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVXL...
Open
1,05 $
High
1,06 $
Low
0,98 $
Mkt. cap
91,71 млн
Avg. vol.
1,28 млн
Volume
122,00
52-wk high
7,25 $
52-wk low
0,98 $
EPS
-0,15 $
Beta
1,24
Shares outstanding
92,70 млн
No. of employees
34
Open
1,05 $
High
1,06 $
Low
0,98 $
Mkt. cap
91,71 млн
Avg. vol.
1,28 млн
Volume
122,00
52-wk high
7,25 $
52-wk low
0,98 $
EPS
-0,15 $
Beta
1,24
Shares outstanding
92,70 млн
No. of employees
34
News stories
From web sources and news partners
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersНью-Йорк, Нью-Йорк, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websiteanavex.com
Analyst
Recommendation
Action
Price target
Projected
Date
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
20,00 $
+1 921,4%
05/04/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
20,00 $
+1 921,4%
03/31/2026
Soumit Roy
JonesTrading
Hold
Maintained
-
-
11/14/2025
Last report
2026 ж. 25 там.
Fiscal period
Q3 2026
0,08 $ / -0,08 $
+200,00%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,28 млн
4,62 млн
4,16 млн
-4,74 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,55 млн
2,13 млн
2,29 млн
-2,03 млн
Operating expense
10,83 млн
6,75 млн
6,46 млн
-6,77 млн
Total operating expenses
10,83 млн
6,75 млн
6,46 млн
-6,77 млн
Operating income
-10,83 млн
-6,75 млн
-6,46 млн
6,77 млн
Other non operating income
-
-
-
-
EBT including unusual items
-9,83 млн
-5,66 млн
-5,34 млн
7,82 млн
EBT excluding unusual items
-9,83 млн
-5,66 млн
-5,34 млн
7,82 млн
Income tax expense
-
18,00 мың
-
-
Effective tax rate
-
-0,32%
-
-
Other operating expenses
-
-
-
-
Net income
-9,83 млн
-5,68 млн
-5,34 млн
7,82 млн
Net profit margin
-
-
-
-
Earnings per share
-0,11
-0,06
-0,06
0,08
Interest and investment income
999,00 м.
1,08 млн
1,06 млн
1,07 млн
Interest expense
-
-
-
-
Net interest expenses
999,00 м.
1,08 млн
1,06 млн
1,07 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары